A Search Service for Abbreviation / Long Form

■検索結果 - 略語 : TIME

検索条件

検索語：TIME

検索方法：完全一致

主な研究分野:

結果

略語: TIME

出現頻度: 1531

対応する展開形の数: 70

No.

展開形

主な研究分野

共起略語

PubMed/MEDLINE情報 (発表年, 題目)

tumor immune microenvironment

(1337回)

Neoplasms

新生物, 腫瘍

(416回)

HCC(112回)

OS(106回)

ICIs(84回)

2018Understanding the tumor immune microenvironment (TIME) for effective therapy.

tumor immunosuppressive microenvironment

(30回)

Biomedical Engineering

生物医工学

(8回)

ICD(7回)

DCs(6回)

TAMs(6回)

2021Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.

transverse intrafascicular multichannel electrode

(19回)

Biomedical Engineering

生物医工学

(11回)

PNS(2回)

AIR(1回)

FEM(1回)

2010A transverse intrafascicular multichannel electrode (TIME) to interface with the peripheral nerve.

Treatment In Morning versus Evening

(16回)

Medicine

医学, 医薬

(6回)

BP(3回)

HBPM(2回)

MI(2回)

2015Poster advertisements in practice waiting rooms to recruit patients to the Treatment In Morning vs. Evening (TIME) online study.

Treatment of Neuropsychiatric Symptoms

(10回)

Health Services Research

保険医療研究

(3回)

NPS(2回)

RCT(2回)

BPSD(1回)

2016TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial.

tumor microenvironment

腫瘍微小環境

(8回)

Allergy and Immunology

アレルギー・免疫

(2回)

ICD(2回)

AA(1回)

AMPK(1回)

2021Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells.

telomerase-immortalized human microvascular endothelial

(8回)

Medicine

医学, 医薬

(2回)

VEGF(2回)

bFGF(1回)

HMEC-1(1回)

2002Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells.

Tumor Immunity in the MicroEnvironment

(7回)

Neoplasms

新生物, 腫瘍

(3回)

OS(2回)

PFS(2回)

TIL(2回)

2016Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy.

Teaching Immunization for Medical Education

(7回)

Primary Health Care

一次医療

(4回)

MCTS(2回)

CDC(1回)

CI(1回)

1996Pertussis, pertussis vaccine, and care of exposed persons.

trauma-informed medical education

(6回)

Education

教育

(2回)

TIC(2回)

DV(1回)

EM(1回)

2020Trauma-Informed Medical Education (TIME): Advancing Curricular Content and Educational Context.

Turkish inappropriate medication use in the elderly

(5回)

Geriatrics

老年医学

(2回)

HR(2回)

CI(1回)

NRS-2002(1回)

2020Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START.

tumor inflammatory microenvironment

(3回)

General Surgery

外科学

(1回)

ADCs(1回)

CRC(1回)

dMMR(1回)

2024Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers.

tissue, infection, moisture, edge

(3回)

Nursing

看護学

(2回)

HRQoL(1回)

set(1回)

PUs(1回)

2004TIME principles of chronic wound bed preparation and treatment.

Time Interval Measuring Enzyme

(3回)

Zoology

動物学

(2回)

PIN(1回)

2004Demarcation of diapause development by cold and its relation to time-interval activation of TIME-ATPase in eggs of the silkworm, Bombyx mori.

Transformation in Medical Education

(3回)

Medicine

医学, 医薬

(1回)

PIF(2回)

UGME(1回)

2011It's About TIME.

Toddler Infant Motor Evaluation

(3回)

Pediatrics

小児科学, 小児医学

(2回)

GH(2回)

PWS(2回)

DEXA(1回)

1993Sequence comparison methodology for the analysis of movement patterns in infants and toddlers with and without motor delays.

triple-I mediator education

(2回)

Medicine

医学, 医薬

(2回)

2022Programme of triple-I mediator education (TIME) to improve medical disputes in clinical settings in Taiwan: a Delphi study.

tumor immunological microenvironment

(2回)

Medicine

医学, 医薬

(1回)

CCK-8(1回)

CTLs(1回)

HCC(1回)

2021A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma.

theatre information, management and efficiency

(2回)

Health Services

公共医療

(1回)

1999Better theatre management through intelligent reporting: the TIME (theatre information, management and efficiency) system.

Tumor Immune Estimation Resource

(2回)

Neoplasms

新生物, 腫瘍

(2回)

COAD(1回)

FSTL1(1回)

GC(1回)

2020Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.